Assignee
VELOXIS PHARMACEUTICALS AS
DK·18 granted patents·3 pending applications·64 citations·filing 2012–2020
Top patents by PatentIndex Score
21 records- 0196US11110081B2Tacrolimus for improved treatment of transplant patientsVELOXIS PHARMACEUTICALS AS·Filed 2020·Granted Sep 7, 2021·4 cites·28 claims
- 0295US8889186B2Modified release compositions comprising tacrolimusVELOXIS PHARMACEUTICALS AS·Filed 2013·Granted Nov 18, 2014·17 cites·18 claims
- 0393US11123331B2Tacrolimus for improved treatment of transplant patientsVELOXIS PHARMACEUTICALS AS·Filed 2020·Granted Sep 21, 2021·2 cites·25 claims
- 0493US8889185B2Modified release compositions comprising tacrolimusVELOXIS PHARMACEUTICALS AS·Filed 2013·Granted Nov 18, 2014·11 cites·29 claims
- 0592US9775834B2Regimen for supressing organ rejectionVELOXIS PHARMACEUTICALS AS·Filed 2015·Granted Oct 3, 2017·4 cites·9 claims
- 0690US11141408B2Regimen for suppressing organ rejectionVELOXIS PHARMACEUTICALS AS·Filed 2019·Granted Oct 12, 2021·2 cites·24 claims
- 0790US10548880B2Solid dispersions comprising tacrolimusVELOXIS PHARMACEUTICALS AS·Filed 2017·Granted Feb 4, 2020·4 cites·16 claims
- 0890US9168246B2Regimen for suppressing organ rejectionVELOXIS PHARMACEUTICALS AS·Filed 2014·Granted Oct 27, 2015·5 cites·11 claims
- 0990US9161907B2Modified release compositions comprising tacrolimusVELOXIS PHARMACEUTICALS AS·Filed 2013·Granted Oct 20, 2015·6 cites·24 claims
- 1088US10864199B2Tacrolimus for improved treatment of transplant patientsVELOXIS PHARMACEUTICALS AS·Filed 2016·Granted Dec 15, 2020·2 cites·19 claims
- 1188US9763920B2Solid dispersions comprising tacrolimusVELOXIS PHARMACEUTICALS AS·Filed 2015·Granted Sep 19, 2017·3 cites·30 claims
- 1282US11129815B2Solid dispersions comprising tacrolimusVELOXIS PHARMACEUTICALS AS·Filed 2019·Granted Sep 28, 2021·0 cites·12 claims
- 1382US10485793B2Regimen for suppressing organ rejectionVELOXIS PHARMACEUTICALS AS·Filed 2017·Granted Nov 26, 2019·2 cites·18 claims
- 1479US9757362B2Modified release compositions comprising tacrolimusVELOXIS PHARMACEUTICALS AS·Filed 2015·Granted Sep 12, 2017·1 cites·8 claims
- 1575US11077096B2Modified release compositions comprising tacrolimusVELOXIS PHARMACEUTICALS AS·Filed 2017·Granted Aug 3, 2021·0 cites·13 claims
- 1673US10166190B2Stabilized tacrolimus compositionVELOXIS PHARMACEUTICALS AS·Filed 2017·Granted Jan 1, 2019·1 cites·16 claims
- 1769US11419823B2Stabilized tacrolimus compositionVELOXIS PHARMACEUTICALS AS·Filed 2018·Granted Aug 23, 2022·0 cites·28 claims
- 1865US2013189318A1Solid dispersions comprising tacrolimusVELOXIS PHARMACEUTICALS AS·Filed 2012·Application pending·0 cites
- 1963US2014179731A1Tacrolimus For Improved Treatment Of Transplant PatientsVELOXIS PHARMACEUTICALS AS·Filed 2013·Application pending·0 cites
- 2054US9295653B2Controlled agglomerationVELOXIS PHARMACEUTICALS AS·Filed 2013·Granted Mar 29, 2016·0 cites·27 claims
- 2147US2015164812A1Porous Tablets As Carriers For Liquid FormulationsVELOXIS PHARMACEUTICALS AS·Filed 2015·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →